Tired of long waits and rushed appointments? Learn why patients and physicians alike are finding concierge medicine more ...

Violence, music, money, a meteoric rise and a faster fall. Sean 'Diddy' Combs had it all until his life and crimes brought ...

The growth of the complicated urinary tract infections market is expected to be mainly driven by the entry of new therapies such as Tebipenem Pivoxil Hydrobromide (SPR994), ZAYNICH ...

Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...

Urinary incontinence (UI) minimally affected academic performance except in children with psychiatric disorders. Children ...

Many people try to urinate "just in case" before heading out the door or sitting down to watch a movie. While that's fine ...

The short answer? Not really. The full picture reveals a more complex – and far more interesting – interplay between anatomy, ...

“There is also some data to suggest that people who suffer from recurrent UTIs may also have genetic factors which predispose ...

Since the emergence of the Zika virus epidemic in 2014 and the associated novel sequalae that emerged, much has been learned about the effects of antenatal exposure to Zika virus. Zika virus in ...

Updated guidance offers evidence-based strategies to optimize the diagnosis and treatment of non-metastatic upper tract ...

Frequent urination in a person with a uterus has many causes, including diabetes, bladder stones, an overactive bladder, and pregnancy. Learn more here.

The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary tract infections (uUTIs) in nearly 30 years, after a priority review.